Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KAYLA R COTTRILL

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner

NPI
1073992327
CMS profile
11083624
Location
WARSAW, IN

General Payments · PY2021–2024

$903.70

  • Reported across 55 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$278.70

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $278.70 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $231.40 15
PY2022 $152.25 9
PY2023 $241.35 15
PY2024 $278.70 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $15.81 03/27/2024 Food and Beverage Undisputed 01/23/2026 1124829245 CMS
Astellas Pharma US Inc $23.34 02/14/2024 Food and Beverage Undisputed 01/23/2026 1139489394 CMS
Astellas Pharma US Inc $14.34 07/10/2024 Food and Beverage Undisputed 01/23/2026 1139470390 CMS
AstraZeneca Pharmaceuticals LP $21.49 02/09/2024 Food and Beverage Undisputed 01/23/2026 1104677399 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.01 02/21/2024 Food and Beverage Undisputed 01/23/2026 1117863931 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.87 08/27/2024 Food and Beverage Undisputed 01/23/2026 1117863929 CMS
Dexcom, Inc. $14.26 03/05/2024 Food and Beverage Undisputed 01/23/2026 1153370783 CMS
GlaxoSmithKline, LLC. $15.47 11/08/2024 Food and Beverage Undisputed 01/23/2026 1116565284 CMS
Lilly USA, LLC $14.96 01/18/2024 Food and Beverage Undisputed 01/23/2026 1135735537 CMS
Lilly USA, LLC $14.06 04/15/2024 Food and Beverage Undisputed 01/23/2026 1135771072 CMS
Novo Nordisk Inc $15.83 01/09/2024 Food and Beverage Undisputed 01/23/2026 1100242534 CMS
Novo Nordisk Inc $19.87 01/17/2024 Food and Beverage Undisputed 01/23/2026 1100598479 CMS
Novo Nordisk Inc $20.22 04/03/2024 Food and Beverage Undisputed 01/23/2026 1100236554 CMS
Novo Nordisk Inc $18.67 10/09/2024 Food and Beverage Undisputed 01/23/2026 1100601685 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.98 05/13/2024 Food and Beverage Undisputed 01/23/2026 1153568190 CMS
Xeris Pharmaceuticals, Inc. $16.52 02/13/2024 Food and Beverage Undisputed 01/23/2026 1144631075 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.